Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|September 1, 1999
Supplements and Featured Publications
- New Treatments for Rheumatoid Arthritis: A Managed Care Perspective
- Volume 5
- Issue 14 Suppl
Managed Care Issues and Rheumatoid Arthritis Treatment
Author(s)Michael Ward, MD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Introductionabout 27 years ago
Treatment Options for Rheumatoid Arthritisabout 27 years ago
The Burden of Rheumatoid Arthritisabout 27 years ago
Faculty Question-and-Answer Sessionabout 27 years ago
Roundtable I: Practice Patterns for Treating Rheumatoid Arthritisabout 27 years ago
Roundtable II: Cost Concerns for Rheumatoid Arthritis Treatmentabout 27 years ago
Selected Abstractsabout 27 years ago
CME QuizAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Amid SOHO Data, Reviewers of BTK Inhibitors in MCL Call for Trials
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
4
Cross-Trial Vitiligo Data: What Payers Can and Can't Compare
5